Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthma

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 1, 1999, Pages 46-52

  McFadden, E R ^a   Casale, Thomas B ^b   Edwards, Thomas B ^c,h   Kemp, James P ^d   Metzger, W James ^e   Nelson, Harold S ^f   Storms, William W ^g   Neidl, Michael J ⁱ  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Nebraska Medical Research Institute   (United States)

^c Allerg and Asthma Ctr of Albany M   (United States)

^d ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^g Asthma & Allergy Associates PC and Research Center   (United States)

^h Berkshire Associates   (United States)

ⁱ NONE

Author keywords

Asthma; Budesonide; Glucocorticosteroids; Inhalation; Once daily; Quality of life; Turbuhaler

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; GLUCOCORTICOID; PLACEBO;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PEAK EXPIRATORY FLOW; POWDER INHALER; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

EID: 0032838943     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70112-0     Document Type: Article

References (23)

1. 1. US Department of Health and Human Services, Centers for Disease Control and Prevention. Morbidity and mortality: 1996 chartbook on cardiovascular, lung and blood diseases. Bethesda (MD): The National Institutes of Health; National Heart, Lung and Blood Institute; May 1996.
2. 2. National Asthma Education Program. Expert panel report: guidelines for the diagnosis and management of asthma. Washington (DC): US Department of Health and Human Services; August 1991. Publication no. 91-3042.
3. 3. National Asthma Education Program: Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; National Heart, Lung and Blood Institute; April 1997. NIH Publication no. 91-4051.
4. 4. Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998; 102:705-13.
5. 5. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:8-14.
6. 6. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: Is there a solution to the problem? Ann Allergy 1997;79:177-86.
7. 7. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148;S1-26.
8. 8. Edsbäcker S. Systemic and pulmonary availability of budesonide. In: Jackson B, editor. Budesonide Turbuhaler. Oxfordshire: Clinical Vision Ltd; 1993. p. 10-1.
9. 9. Thorsson C, Edsbäcker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (P-MDI). Eur Respir J 1994;7:1839-44.
10. 10. Busse WW, Chervinsky P, Condemi J, Lumry W, Petty T, Rennard S, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457-63.
11. 11. Campbell LM, Gunn SD, Sweeney D, Smithers AJ, Zurek AAA, Golightly L, et al. Once daily budesonide: effective control of moderately severe asthma with 800 μg once daily inhaled via turbuhaler when compared with 400 p.g twice daily. Eur J Clin Res 1995;7:1-14.
12. 12. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankant JPI, Fellows RM, et al. Pulmicort Turbuhaler once daily as initial prophylactic therapy for asthma. Respir Med 1994;88:293-9.
13. 13. Campbell LM, Watson DC, Venables TL, Taylor MD, Richardson PDI. Once daily budesonide Turbuhaler compared with placebo as initial prophylactic therapy for asthma. Br J Clin Res 1991;2:111-22.
14. 14. Venables TL, Addlestone MB, Smithers AJ, Blagden MD, Weston D, Gooding T, et al. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via Disc-Inhaler at an equal daily dose of 400 μg in adult asthmatics. Br JClin Res 1996;7:15-32.
15. 15. Chrisholm SL, Decker FW, Knuistingh Nevin A, Petri H. Once-daily budesonide in mild asthma. Respir Med 1998;92:421-5.
16. 16. Juniper EF, Guyatt GH, Feme PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147:832-8.
17. 17. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol 1994;47:81-7.
18. 18. Engel T, Heinig JH, Malling HJ. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy 1989;44:220-5.
19. 19. ZuWallack RL, Rosen JP, Cohen L, Rachelefsky GS, Gong H, Goldsobel AB, et al. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. J Allergy Clin Immunol 1997;89:278-85.
20. 20. Gagnon M, Côte J, Milot J, Turcotte H, Boulet L-P. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. Chest 1994;105:1732-7.
21. 21. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995;95:1172-8.
22. 22. Malo JL, Cartier A, Merland N, Ghezzo H, Burek A, Morris J, et al. Four-times-a day dosing frequency is better than twice-a-day regimen in subjects requiring a high dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989;140:624-8.
23. 23. Toogood JH, Baskerville JC, Jennings B, Lefcoe MD, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982;70:288-98.